Skip to content

Clinical trials

Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Italy Clear all

571 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20034
20043
200513
200614
200714
200817
200918
201017
201119
201221
201322
201419
201523
201627
201726
201834
201953
202034
202140
202231
202325
202438
202533
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed268
Recruiting107
Active, not recruiting68
Terminated56
Unknown status55
Not yet recruiting11
Enrolling by invitation4
Available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals35
AbbVie30
Amgen15
AstraZeneca15
GlaxoSmithKline15
Bayer14
Pfizer12
Azienda USL Reggio Emilia - IRCCS11
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano11
Hoffmann-La Roche11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms571
Neoplasm Metastasis59
Carcinoma, Non-Small-Cell Lung57
Breast Neoplasms56
Colorectal Neoplasms43
Lung Neoplasms41
Neoplasms by Site29
Recurrence29
Carcinoma23
Melanoma23

Trials

Showing 1 to 25 of 571. Each trial links to its page on Pharma Observatory.

471 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.